Synchronous bronchioloalveolar and squamous cell lung cancer with different 18F-FDG avidity on PET/CT.

Standard

Synchronous bronchioloalveolar and squamous cell lung cancer with different 18F-FDG avidity on PET/CT. / Derlin, Thorsten; Clauditz, Till; Quaas, Alexander; Habermann, Christian.

in: CLIN NUCL MED, Jahrgang 37, Nr. 10, 10, 2012, S. 255-256.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{193cbde3e3454ae798c92b0439d01bc1,
title = "Synchronous bronchioloalveolar and squamous cell lung cancer with different 18F-FDG avidity on PET/CT.",
abstract = "We report a case of synchronous multiple primary lung cancer diagnosed by 18F-FDG PET/CT. A 78-year-old man underwent staging FDG PET/CT that demonstrated intense tracer uptake in the primary, and a second lesion with low uptake. Histopathologic evaluation revealed synchronous squamous cell and bronchioloalveolar carcinoma, representing 2 distinct primaries. FDG PET/CT may identify and diagnose synchronous multiple primary lung cancer on the basis of different morphologic and metabolic features of distinct tumor entities. Moreover, pulmonary lesions with low FDG avidity may still represent malignant disease, even in the context of biopsy-proven FDG-avid lung cancer.",
keywords = "Humans, Male, Aged, Biological Transport, *Positron-Emission Tomography and Computed Tomography, Fluorodeoxyglucose F18/*diagnostic use/metabolism, Adenocarcinoma, Bronchiolo-Alveolar/metabolism/pathology/*radionuclide imaging, Lung Neoplasms/metabolism/pathology/*radionuclide imaging, Neoplasms, Multiple Primary/metabolism/pathology/*radionuclide imaging, Neoplasms, Squamous Cell/metabolism/pathology/*radionuclide imaging, Humans, Male, Aged, Biological Transport, *Positron-Emission Tomography and Computed Tomography, Fluorodeoxyglucose F18/*diagnostic use/metabolism, Adenocarcinoma, Bronchiolo-Alveolar/metabolism/pathology/*radionuclide imaging, Lung Neoplasms/metabolism/pathology/*radionuclide imaging, Neoplasms, Multiple Primary/metabolism/pathology/*radionuclide imaging, Neoplasms, Squamous Cell/metabolism/pathology/*radionuclide imaging",
author = "Thorsten Derlin and Till Clauditz and Alexander Quaas and Christian Habermann",
year = "2012",
language = "English",
volume = "37",
pages = "255--256",
journal = "CLIN NUCL MED",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

RIS

TY - JOUR

T1 - Synchronous bronchioloalveolar and squamous cell lung cancer with different 18F-FDG avidity on PET/CT.

AU - Derlin, Thorsten

AU - Clauditz, Till

AU - Quaas, Alexander

AU - Habermann, Christian

PY - 2012

Y1 - 2012

N2 - We report a case of synchronous multiple primary lung cancer diagnosed by 18F-FDG PET/CT. A 78-year-old man underwent staging FDG PET/CT that demonstrated intense tracer uptake in the primary, and a second lesion with low uptake. Histopathologic evaluation revealed synchronous squamous cell and bronchioloalveolar carcinoma, representing 2 distinct primaries. FDG PET/CT may identify and diagnose synchronous multiple primary lung cancer on the basis of different morphologic and metabolic features of distinct tumor entities. Moreover, pulmonary lesions with low FDG avidity may still represent malignant disease, even in the context of biopsy-proven FDG-avid lung cancer.

AB - We report a case of synchronous multiple primary lung cancer diagnosed by 18F-FDG PET/CT. A 78-year-old man underwent staging FDG PET/CT that demonstrated intense tracer uptake in the primary, and a second lesion with low uptake. Histopathologic evaluation revealed synchronous squamous cell and bronchioloalveolar carcinoma, representing 2 distinct primaries. FDG PET/CT may identify and diagnose synchronous multiple primary lung cancer on the basis of different morphologic and metabolic features of distinct tumor entities. Moreover, pulmonary lesions with low FDG avidity may still represent malignant disease, even in the context of biopsy-proven FDG-avid lung cancer.

KW - Humans

KW - Male

KW - Aged

KW - Biological Transport

KW - Positron-Emission Tomography and Computed Tomography

KW - Fluorodeoxyglucose F18/diagnostic use/metabolism

KW - Adenocarcinoma, Bronchiolo-Alveolar/metabolism/pathology/radionuclide imaging

KW - Lung Neoplasms/metabolism/pathology/radionuclide imaging

KW - Neoplasms, Multiple Primary/metabolism/pathology/radionuclide imaging

KW - Neoplasms, Squamous Cell/metabolism/pathology/radionuclide imaging

KW - Humans

KW - Male

KW - Aged

KW - Biological Transport

KW - Positron-Emission Tomography and Computed Tomography

KW - Fluorodeoxyglucose F18/diagnostic use/metabolism

KW - Adenocarcinoma, Bronchiolo-Alveolar/metabolism/pathology/radionuclide imaging

KW - Lung Neoplasms/metabolism/pathology/radionuclide imaging

KW - Neoplasms, Multiple Primary/metabolism/pathology/radionuclide imaging

KW - Neoplasms, Squamous Cell/metabolism/pathology/radionuclide imaging

M3 - SCORING: Journal article

VL - 37

SP - 255

EP - 256

JO - CLIN NUCL MED

JF - CLIN NUCL MED

SN - 0363-9762

IS - 10

M1 - 10

ER -